Pharmaceutical Case Studies
Therapy Area/Business Area
Auto-Immune/Early Commercial Development
The Business Issue
- Should the R&D and Marketing teams make significant further investment in funding Phase II trials for this novel Quinolone drug indicated for anti-MRSA activity for HAP, VAP and SSTI?
The Impact
- Redefine the TPP and support the decision to move the drug through Phase II
The SmartAnalyst Approach
- Produce scope in collaboration with client
- Market Opportunity Assessment including primary market research findings
- A revenue forecast model which was presented to senior management
The Output (4 week turnaround)
- Collection and analysis of a wide and complex range of secondary data
- Primary market research and expert analysis that would reduce the massive amount of information to a go/no-go recommendation
Intelligent Insights. Smart Results.
